Skip to main content

Oxford to study anti-inflammatory drug as potential COVID-19 treatment

Image
By Admin
Oxford to study anti-inflammatory drug as potential COVID-19 treatment
Oxford University said on Wednesday it would study whether the world’s best-selling prescription medicine, adalimumab, was an effective treatment for COVID-19 patients – the latest effort to repurpose existing drugs as potential coronavirus therapies.

Adalimumab, which is sold under the brand name Humira by AbbVie, is a type of anti-inflammatory known as an anti-tumour necrosis factor (anti-TNF) drug. Recent studies have shown that COVID-19 patients already taking anti-TNF drugs for inflammatory bowel disease and inflammatory arthritis are less likely to be admitted to hospital, Oxford said in a statement.

Oxford’s trial, called AVID-CC, will be aimed at treating people in the community, especially in care homes, the university said. It will enrol up to 750 patients from community care settings throughout Britain.

Humira is used to treat a range of conditions including rheumatoid arthritis, Crohn’s disease, ulcerative colitis and psoriasis.

The availability of biosimilar versions of the medicine would make it affordable and accessible if the trial is successful, Oxford said. Novartis makes one of the alternatives, Hyrimoz.

Research has identified some treatments for hospitalised COVID-19 patients, including Gilead’s remdesivir as well as the generic steroid drug dexamethasone.

Researchers have also studied other anti-inflammatory drugs for treating COVID-19. Severe infections are believed to be triggered by an over-reaction of the immune system, known as a cytokine storm, and drugs that suppress certain elements of the immune system can play a role in arresting a rapid escalation of symptoms.

But there are as yet no effective therapies for people who are not admitted to hospital.

Care homes were particularly hard hit by the first wave of COVID-19 in the UK and other countries. If Humira were successful against COVID-19, this could help some older people who are some of most vulnerable, it said, at a time when governments are struggling to contain the pandemic.

The Oxford study is funded by the COVID-19 Therapeutics Accelerator initiative set up by global health charity Wellcome, as well as the Bill and Melinda Gates Foundation and Mastercard.

Labels:

Comments

Post a Comment

Popular posts from this blog

Army chief assures business community of ‘complete support’ for economic uplift

By Admin
Chief of Army Staff Gen Qamar Javed Bajwa on Wednesday assured the business community of the army’s “complete support” for the economic uplift of the country. He made this assurance during a meeting with businessmen who called on him at the General Headquarters today, according to a statement by the military’s media affairs wing. A delegation of the Federation of Pakistan Chambers of Commerce & Industry (FPCCI) and the army chief discussed the “evolving regional economic environment” as well as the FPCCI’s role in the development of commercial and industrial hubs in Pakistan, the Inter-Services Public Relations (ISPR) said. During the meeting, Gen Bajwa appreciated the role of the business community in the economic uplift of the country and affirmed all-out support of the army in this regard. The delegation, meanwhile, acknowledged the Pakistan Army’s role and sacrifices in the provision of a "secure enabling environment" for economic prosperity in the country, acco...
Post a Comment
Read more

3rd U-19 Women T20: South Africa beat Pakistan by 52 runs

By
In the third T20 of the five-match series in Karachi, South Africa Under-19 women's team defeated Pakistan Under-19 women's team by 52 runs tonight. Batting first, South Africa Under-19 women's team scored 158 runs for the loss of six wickets in allotted 20 overs. In reply, Pakistan Under-19 women's team were all out for 106 runs in 18 overs. South Africa lead the series 2-1.
Post a Comment
Read more

Military court case: SC rejects govt plea for constitution of full court bench

By
The Supreme Court of Pakistan has rejected a government plea to constitute a full court bench to decide the issue of civilian trials in military courts. The government had urged the court to set up a full court on the question. The was heard by a six-member larger bench headed by Chief Justice Umar Ata Bandial, which reserved its judgment on Tuesday. The bench ruled that judges were not available for the constitution of full court bench due to summer vacations. The bench includes Justice Ijazul Ahsan, Justice Muneeb Akhtar, Justice Yahya Afridi, Justice Mazahar Ali Akbar Naqvi and Justice Ayesha Malik. The Chief Justice of the Supreme Court remarked during the hearing yesterday (on Tuesday) that there should be an independent body to review whether the arrests were made on valid grounds or not. The attorney general of Pakistan submitted the details of 102 people who face military trials to the court. Justice Mazahir Naqvi said in his remarks why other accused in the same case ...
Post a Comment
Read more